Improvement of cytomegalovirus-related Guillain-Barré syndrome after high doses of intravenous methylprednisolone pulses.
Beauvais
Katell
K
Furby
Alain
A
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000472:pathogenicity*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D020275:Guillain-Barre Syndrome / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D007275:Injections, Intravenous / Q000379:methods; D008775:Methylprednisolone / Q000627:therapeutic use*; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone